Emamectin benzoate-chlorantraniliprole dispersible oil suspending agent and preparation method thereof

The stability of the agent under low temperature and heat storage is solved by using fused ring compounds, composite emulsifiers, ionic surfactants, bentonite and vapor-phase silica in the methylvitamin dispersible oil suspension agent. and improve spray performance and pest control effect.

CN118923681APending Publication Date: 2024-11-12吉林金泽农药有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410980205.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing methylvitaminophenone dispersible oil suspension agent is prone to change during preparation and use, resulting in difficulty in preparation and unstable storage. It is easy to form ointments or floating substances when used in low-temperature water, affecting the normal sprayer Work.

Method used

Using fused ring compounds as functional additives, vegetable oil as oil-based dispersion medium, composite emulsifiers and ionic surfactants as emulsifiers and dispersants, and a mixture of bentonite and vapor phase silica as stabilizers, through specific formulations and optimize the process steps to form a stable suspension system.

Benefits of technology

It significantly improves the thermal storage stability, low temperature stability and spray performance of the agent, enhances the adhesion of the drug film and the resistance to rainwater erosion, and improves the control effect on pests.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004955830520000021
    Figure BDA0004955830520000021
  • Figure BDA0004955830520000121
    Figure BDA0004955830520000121
  • Figure BDA0004955830520000131
    Figure BDA0004955830520000131
Patent Text Reader

Abstract

The invention relates to the technical field of dispersible oil suspending agents, in particular to an emamectin benzoate-chlorantraniliprole dispersible oil suspending agent and a preparation method thereof. The oil-based pesticide composition comprises the following components in parts by weight: 10-30 wt% of chlorantraniliprole, 1-10 wt% of emamectin benzoate, 1-4.5 wt% of a dispersant, 3-12 wt% of an emulsifier, 0.1-2 wt% of a stabilizer, 0.5-2 wt% of a functional aid and the balance of an oil-based dispersion medium, wherein the functional auxiliary agent is a fused ring compound, and the fused ring compound is a carboxylate fused ring compound; the oil-based dispersion medium is a composite medium containing vegetable oil and mineral oil; the emulsifying agent is a compound emulsifying agent containing at least two or more emulsifying components with different HLB (Hydrophile-Lipophile Balance) values, and the compound emulsifying agent comprises an emulsifying agent with the HLB value not higher than 10. Through targeted optimization and improvement of the emulsifier, the dispersant, the stabilizer and other components in the formula, the active components achieve good dispersion and emulsification effects, and the heat storage stability, dumping property, low-temperature stability and other characteristics of the preparation are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of dispersible oil suspensions, and in particular to an emamectin benzoate-chlorantraniliprole dispersible oil suspension and a preparation method thereof. Background Art

[0002] Dispersible oil suspension is a highly dispersed, non-aqueous medium oil phase suspension system made of the original drug and suitable adjuvants and auxiliary raw materials, with the oil phase as the carrier. After the agent is diluted with water and sprayed on the plant or target, it is easy to form a drug film. According to the principle of like affinity, like compatibility, it has strong permeability, good adhesion, and is resistant to rain erosion. The efficacy is better and the utilization rate of the effective ingredients is high. Chlorantraniliprole is a para-formylaminobenzamide insecticide with a new insecticidal mechanism. It has both very good permeability and excellent systemicity. After being applied to crops, it can be quickly absorbed by the crops and transmitted from bottom to top through the xylem of the crops to various parts and tissues of the crops, thereby comprehensively protecting the crops. Emamectin benzoate is emamectin benzoate, which has both contact and stomach poisoning effects, and has unparalleled activity against many pests, especially against Lepidoptera and Diptera pests, such as cotton bollworm, beet armyworm, cutworm, diamondback moth, cabbage worm, armyworm, stem borer, etc. Emamectin benzoate and chlorfenapyr dispersible oil suspensions are provided in the prior art, such as Chinese patent CN111226914A, in which the stability of the dispersible oil suspension is improved by using components such as alkoxylated tallow alcohol and isosorbide derivatives.

[0003] However, the applicant found in the process of studying the preparation process of chlorfenapyr dispersible oil suspension that the emulsified state of the agent is easy to change during the preparation and use. For example, when the emulsifier, wetting and penetrant components used in the dosage form are not properly matched, emulsification is difficult during the preparation process, and it takes longer time and energy to prepare the available agent. Moreover, the dispersion state of these agents will also change after hot storage, affecting their normal storage and use. In addition, the applicant also found that farmers often use local materials when using these agents, such as directly using groundwater or well water, which is often at a very low temperature and may even contain turbid substances. When the agent is mixed in these waters, when the agent is sprayed by a sprayer, it is easy to form a layer of ointment or floating objects on the water surface, blocking the sprayer head and affecting normal spraying. Summary of the invention

[0004] In view of the above technical problems, the present invention provides an emamectin benzoate-chlorantraniliprole dispersible oil suspension, which comprises the following components in parts by weight:

[0005]

[0006] Among them, the functional auxiliary agent is a condensed ring compound, and the condensed ring compound is a carboxylate condensed ring compound; the oil-based dispersion medium is vegetable oil; the emulsifier is a composite emulsifier containing at least two or more emulsifying components with different HLB values, and the composite emulsifier includes an emulsifier with an HLB value not higher than 10; the dispersant is an ionic surfactant.

[0007] As a preferred technical solution of the present invention, the composite emulsifier includes a primary emulsifier, and the HLB value of the primary emulsifier is not higher than 6; the content of the primary emulsifier accounts for at least 50wt% or more of the total content of the composite emulsifier; preferably, the composite emulsifier also includes an auxiliary emulsifier, and the HLB value of the auxiliary emulsifier is higher than that of the primary emulsifier.

[0008] As a preferred technical solution of the present invention, the composite emulsifier further includes an auxiliary emulsifier, and the auxiliary emulsifier includes at least two emulsifier components with different HLB values.

[0009] As a preferred technical solution of the present invention, the auxiliary emulsifier includes a high HLB value emulsifier and a low HLB value emulsifier, the HLB value of the high HLB value emulsifier is 13-16, and the HLB value of the low HLB value emulsifier is 7-10; preferably, the mass ratio of the high HLB value emulsifier to the low HLB value emulsifier is 1:(1.5-2.5).

[0010] As a preferred technical solution of the present invention, the dispersant includes polycarboxylate and sulfonate; the mass ratio of the polycarboxylate to the sulfonate is 1:(1-2).

[0011] As a preferred technical solution of the present invention, the stabilizer is a mixture of bentonite and fumed silica; the content of the bentonite is higher than the content of the fumed silica; preferably, the specific surface area of ​​the fumed silica is 250 to 400 m 2 / g.

[0012] As a preferred technical solution of the present invention, the particle size of the bentonite is not higher than 100 μm; the bentonite is composed of modified organic sodium-based bentonite and water-based bentonite.

[0013] As a preferred technical solution of the present invention, the colloidal viscosity of a 3wt% aqueous solution of the aqueous bentonite is not less than 3000cp.

[0014] As a preferred technical solution of the present invention, the functional additive includes sodium rosin acid and / or potassium disproportionated rosin acid.

[0015] The second aspect of the present invention provides a method for preparing the above-mentioned emamectin benzoate-chlorantraniliprole dispersible oil suspension, which comprises the following steps:

[0016] Step 1: taking chlorantraniliprole, emamectin benzoate and functional adjuvant according to the ratio, adding them into a high-speed mixer and mixing to obtain an active component;

[0017] Step 2: adding the emulsifier to the oil-based dispersion medium, stirring and mixing, and then adding the active component and the dispersant under stirring conditions to obtain a mixture;

[0018] Step 3: Add the mixed material into a grinder, shear and grind it into a material with a particle size of less than 5 microns, then add the remaining components, mix, and post-treat to obtain the product.

[0019] Compared with existing related products and solutions, the technical solution provided by the present invention has the following advantages:

[0020] Beneficial effects:

[0021] In the emamectin benzoate dispersible oil suspension provided by the present invention, by optimizing and improving the components such as emulsifier, dispersant, stabilizer in the formula, the active components of chlorantraniliprole and emamectin benzoate can achieve good dispersion and emulsification effects in the dispersible oil suspension preparation, and the dispersion and emulsification effect is equivalent to that of traditional emulsifiable concentrates, and the characteristics such as heat storage stability, pourability, and low-temperature stability of the preparation are significantly improved. Moreover, under the interaction between the above components, the preparation is easy to form a drug film on plants and targets after being diluted with water and sprayed, and the synergistic effect of the above components improves the permeability of the spray, so that the adhesion of the drug film to the surface of the plant and the target is enhanced, thereby further enhancing the resistance to rainwater scouring after the preparation is used, and the drug effect is more powerful. In addition, in the present invention, when preparing the dispersible oil suspension, the active components of chlorantraniliprole and emamectin benzoate are pretreated with sodium rosinate and potassium disproportionate rosinate in advance to activate the surface properties of the above active components, and at the same time improve and promote the interaction between the active component particles and the components such as the dispersant, emulsifier, stabilizer, etc. in the oil-based dispersion medium, thereby improving the comprehensive properties of the preparation, so that the emamectin benzoate dispersible oil suspension of the present invention still has a better effect on the prevention and control of pests such as corn borers when the dosage of the active components is relatively low and the frequency of use is relatively low. DETAILED DESCRIPTION

[0022] When the content, dosage, or other value or parameter in the present application is expressed as a range, a preferred range, or a range defined by a series of upper preferred values ​​and lower preferred values, this should be understood as specifically disclosing all ranges formed by any pairing of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether the range is disclosed separately.

[0023] When numerical ranges are described herein, unless otherwise indicated, the ranges are intended to include the endpoints and all integers and fractions within the range. The singular includes the plural unless the context clearly indicates otherwise. "Optional" or "any" means that the item or event described thereafter may or may not occur, and the description includes situations where the event occurs and situations where the event does not occur.

[0024] The chlorfenapyr dispersible oil suspension provided in the present invention is a dispersible oil suspension containing chlorfenapyr and emamectin benzoate as active ingredients. The dispersible oil suspension described in the present invention is a stable suspension liquid preparation formed by dispersing effective active ingredients in a non-aqueous medium in the form of solid particles, which is well known to those skilled in the art. When the components well known to those skilled in the art and used to prepare the dispersible oil suspension well known to those skilled in the art are omitted during the description of the dispersible oil suspension in the present invention, it should be understood that they can be added and used according to actual needs; similarly, when describing the preparation method of the dispersible oil suspension provided in the present invention, the applicant does not elaborate on the detailed, non-essential steps, process parameters and other information well known to those skilled in the art, and it should be understood that the corresponding preparation process can be adopted and adjusted according to actual needs. The chlorantraniliprole (i.e., chlorantraniliprole) described in the present invention is a compound well known to those skilled in the art, with CAS number: 500008-45-7; the emamectin benzoate (i.e., emamectin benzoate) is a compound well known to those skilled in the art, with CAS number: 155569-91-8.

[0025] The emamectin benzoate-chlorantraniliprole dispersible oil suspension provided by the present invention comprises the following components in parts by weight: 10-30wt% of chlorantraniliprole, 1-10wt% of emamectin benzoate, 1-4.5wt% of dispersant, 3-12wt% of emulsifier, 0.1-2wt% of stabilizer, 0.5-2wt% of functional additive, and the remainder of oil-based dispersion medium; wherein the functional additive is a condensed ring compound, which is a carboxylate condensed ring compound; the oil-based dispersion medium is a vegetable oil; the emulsifier is a composite emulsifier comprising at least two or more emulsifying components with different HLB values, and the composite emulsifier comprises an emulsifier with an HLB value not higher than 10; and the dispersant is an ionic surfactant.

[0026] In the emamectin benzoate / chlorantraniliprole dispersible oil suspension provided by the present invention, the content of chlorantraniliprole is 10-30wt%. For example, the content may be 10wt%, 11wt%, 12wt%, 12.5wt%, 13wt%, 13.5wt%, 14wt%, 14.5wt%, 15wt%, 15.5wt%, 16wt%, 16.5wt%, 17wt%, 18wt%, 19wt%, 20wt%, 21wt%, 22wt%, 23wt%, 24wt%, 25wt%, 26wt%, 27wt%, 28wt%, 29wt%, 30wt% and the like. The content of emamectin benzoate in the emamectin benzoate dispersible oil suspension provided by the present invention is 1-10wt%, and can be exemplified as 1wt%, 1.5wt%, 2wt%, 2.5wt%, 3wt%, 3.5wt%, 4wt%, 4.5wt%, 5wt%, 5.5wt%, 6wt%, 6.5wt%, 7wt%, 7.5wt%, 8wt%, 8.5wt%, 9wt%, 9.5wt%, 10wt% and the like.

[0027] In the dispersible oil suspension of emamectin benzoate provided in the present invention, the dispersant is a component that disperses the water-insoluble active ingredients of chlorantraniliprole and emamectin benzoate in oil to form a stable suspension system during the use of the dispersible oil suspension with water; the dispersant is a surfactant, that is, a compound with certain hydrophilic and hydrophobic properties at the same time, and the dispersant used in the present invention is an ionic surfactant (that is, non-ionic surfactant is not used). The content of the dispersant in the present invention is 1-4.5wt%, and the content can be 1wt%, 1.2wt%, 1.5wt%, 1.8wt%, 2.0wt%, 2.2wt%, 2.5wt%, 2.7wt%, 2.8wt%, 3.0wt%, 3.3wt%, 3.5wt%, 3.8wt%, 4.0wt%, 4.2wt%, 4.3wt%, 4.5wt%, etc.

[0028] Further preferably, the dispersant includes polycarboxylates and sulfonates, wherein the polycarboxylates are polymer salts polymerized by the same or different active monomers (such as acrylic acid, methacrylic acid, maleic acid, etc.), and their molecular structure contains carboxyl active groups; further preferably, the polycarboxylates have a hydrophobic long carbon chain molecular skeleton and a hydrophilic low molecular comb-shaped side chain structure; further preferably, the polycarboxylates have good water solubility, that is, they can be soluble in water, and can be characterized and confirmed according to standards and methods well known to those skilled in the art. The present invention can use, but is not limited to, Shanghai Huntsman Tersperse2700 polyacrylate, etc. The sulfonates described in the present invention can be alkyl sulfonates, or aromatic sulfonates (such as naphthalene sulfonates), etc.; further preferably, the sulfonates are oil-soluble polymers; further preferably, the oil-soluble polymers are anionic sulfonate polymer dispersants; the present invention can use, but is not limited to, sulfonate polymer dispersants including GY-EM05 of Beijing Guangyuan Yinong. The mass ratio of the polycarboxylate to the sulfonate in the dispersant described in the present invention is 1:(1-2); for example, the mass ratio is 1:1, 1:1.1, 1:1.2, 1:1.3, 1:1.4, 1:1.5, 1:1.6, 1:1.7, 1:1.8, 1:1.9, 1:2, etc.; preferably, the content of the sulfonate in the dispersant is at least 1.4 times or more of the content of the polycarboxylate, preferably, the mass ratio of the polycarboxylate to the sulfonate is 1:1.8.

[0029] In the present invention, the above two dispersant components with different molecular structures and characteristics are preferably used, and the ratio of the two is preferably 1: (1-2). The applicant has verified that in the oil-based dispersion medium system of soybean oil and the like of the present invention, when the above two components are used as dispersants, it helps to improve the stability of the dosage form, avoid the agglomeration and sedimentation of the active ingredients, and at the same time, after being diluted with water and sprayed, a uniform and stable film can be formed on the surface of the plant, thereby improving the function of the agent. At the same time, there is an obvious synergistic effect between the above two dispersant components of the present invention and the composite emulsifier. Under the interaction between the two, the dosage of the dispersant components can be reduced, and the surface characteristics of the active ingredients can be activated, so that they are dispersed in the soybean oil in the form of smaller emulsified particles, reducing the sedimentation of oil droplets, and improving the physical and chemical indicators of the preparation such as thermal storage stability and pourability.

[0030] In the dispersible oil suspension of emamectin benzoate and chlorfenapyr provided in the present invention, the emulsifier is a surfactant component that forms micelles in an oil-based dispersion medium and disperses active ingredients that are insoluble in the oil-based dispersion medium in the micelles to form an emulsion dispersion. The emulsifier described in the present invention is a composite emulsifier comprising at least two or more emulsifying components with different HLB values, and the composite emulsifier includes an emulsifier with an HLB value not higher than 10, that is, at least one of the two emulsifying components with different HLB values ​​has an HLB value not higher than 10 (less than or equal to 10, and the HLB values ​​thereof can be exemplified as 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, etc.). The specific molecular structure and composition of the emulsifier are not particularly limited in the present invention, and non-ionic polymer surfactants, anionic surfactants, cationic surfactants, etc. can be used, including but not limited to alkylphenol polyoxyethylene ethers of different molecular structures, ethylene oxide and hydrogenated castor oil condensation products, and long-chain fatty acid esters (such as methyl oleate, stearate, etc.).

[0031] The term "HLB value" in the present invention is the hydrophilic-lipophilic balance value of the emulsifier component, which is used to characterize the size and balance of the hydrophilic and lipophilic groups. The larger the HLB value, the stronger the hydrophilicity; conversely, the stronger the lipophilicity (oil). The HLB value of the emulsifier described in this application can be calculated according to a method well known to those skilled in the art. The emulsifier content described in the present invention is 3 to 12wt%. For example, the emulsifier content can be 3wt%, 3.5wt%, 3.8wt%, 4.0wt%, 4.5wt%, 4.8wt%, 5.0wt%, 5.5wt%, 5.8wt%, 6.0wt%, 6.5wt%, 7.0wt%, 7.5wt%, 8.0wt%, 8.5wt%, 9.0wt%, 9.5wt%, 10wt%, 10.5wt%, 11wt%, 11.5wt%, 12wt%.

[0032] In some preferred embodiments of the present invention, the emulsifier includes a primary emulsifier, and the HLB value of the primary emulsifier is not higher than 6, that is, the HLB value of the primary emulsifier is 0 to 6. For example, the HLB value can be 0.5, 1.0, 1.2, 1.5, 1.8, 2.0, 2.2, 2.5, 2.8, 3.0, 3.3, 3.5, 3.8, 4.0, 4.2, 4.3, 4.5, 4.8, 5.0, 5.5, 6.0, etc.; the content of the primary emulsifier accounts for at least 50wt% or more of the total content of the composite emulsifier; preferably, the content of the primary emulsifier accounts for 50wt% to 60wt% of the total content of the composite emulsifier, and can be listed as 50wt%, 51wt%, 52wt%, 53wt%, 54wt%, 55wt%, 56wt%, 57wt%, 58wt%, 59wt%, 60wt%, etc.

[0033] Further preferably, the composite emulsifier also includes an auxiliary emulsifier, and the HLB value of the auxiliary emulsifier is higher than that of the primary emulsifier, that is, the HLB value of the auxiliary emulsifier is higher than 6; further, the HLB value of the auxiliary emulsifier is 6 to 18, and the HLB values ​​of the auxiliary emulsifier that can be listed can be 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 15.5, 16, 16.5, 17, 17.5, 18 and the like. Further preferably, the auxiliary emulsifier comprises at least two emulsifier components with different HLB values; further preferably, the HLB value difference between the two emulsifier components with different HLB values ​​is at least 3; further preferably, the auxiliary emulsifier comprises a high HLB value emulsifier and a low HLB value emulsifier, the low HLB value emulsifier in the present invention refers to an emulsifier with an HLB value not higher than 10, and the high HLB value emulsifier refers to an emulsifier with an HLB value not lower than 13; further preferably, The HLB value of the high HLB emulsifier is 13 to 16, and the HLB values ​​thereof include 13, 13.2, 13.5, 13.8, 14, 14.2, 14.5, 14.8, 15, 15.5, 15.8, 16, etc.; the HLB value of the low HLB emulsifier is 7 to 10, and the HLB values ​​thereof include 7, 7.2, 7.5, 7.8, 8, 8.3, 8.5, 8.8, 9, 9.2, 9.5, 9.8, 10, etc.

[0034] Preferably, the mass ratio of the high HLB emulsifier to the low HLB emulsifier is 1:(1.5-2.5), and the mass ratio may be 1:1.5, 1:1.6, 1:1.7, 1:1.8, 1:1.9, 1:2, 1:2.1, 1:2.2, 1:2.3, 1:2.4, 1:2.5, etc. Preferably, the mass ratio of the high HLB emulsifier to the low HLB emulsifier is 1:(2-2.5).

[0035] In the process of completing the present invention, the applicant discovered that due to the use of relatively environmentally friendly and low-cost vegetable oils such as soybean oil (HLB value of about 7) as a dispersion medium, the molecular weight is large and the emulsification ability of the active ingredient is poor, which directly affects the use effect of the preparation when diluted with water. Moreover, if the emulsifier components are not properly formulated, it will also cause oil separation and stratification in the oil suspension, which will seriously affect the uniformity of the application of the pesticide, resulting in poor control effect, pesticide damage and other problems. After research, the applicant found that the above-mentioned technical problems can be solved and improved to a certain extent by using a composite emulsifier composed of a low HLB value emulsifier and a high HLB value emulsifier. However, it is not possible to achieve similar effects by randomly compounding any two emulsifiers with different HLB values. The applicant found that when using emulsifiers with different HLB value gradients, and the composite emulsifier obtained by containing at least one emulsifier component with HLB values ​​in the three ranges of 3-6, 7-10 and 13-16, the prepared dispersible oil suspension can not only effectively improve its dispersion effect and emulsification performance during the preparation process, but also maintain good stability at low temperatures, and will not have obvious problems such as oil separation, bottoming, stratification, and creaming.

[0036] In the dispersible oil suspension of chlorfenapyr provided in the present invention, the stabilizer is a component that can delay and reduce the flocculation and sedimentation of the active ingredient in the oil-based dispersion medium, and is helpful to reduce the oil separation rate. The stabilizer described in the present invention adopts a mixture of bentonite and fumed silica. The applicant found that due to the use of vegetable oils such as soybean oil as a dispersion medium, when using traditional hydroxymethyl cellulose, magnesium aluminum silicate and other stabilizers, thickeners and other components widely used in water suspension formulations, they cannot be effectively dispersed in the dispersion medium such as soybean oil of the present invention, and the stabilizing effect on the active components of chlorfenapyr and avermectin benzoate in the present invention is relatively poor. It has been found through experimental verification that the use of a mixture of bentonite and fumed silica in a specific ratio as the stabilizer of the present invention can significantly improve its storage stability and fluidity and other characteristics. The content of the stabilizer in the present invention is 0.1-2wt%, and can be 0.1wt%, 0.2wt%, 0.3wt%, 0.4wt%, 0.5wt%, 0.6wt%, 0.7wt%, 0.8wt%, 0.9wt%, 1.0wt%, 1.1wt%, 1.2wt%, 1.3wt%, 1.4wt%, 1.5wt%, 1.6wt%, 1.7wt%, 1.8wt%, 1.9wt%, 2.0wt% and the like.

[0037] Furthermore, the content of bentonite in the present invention is higher than that of the fumed silica; further, the mass ratio thereof can be 1:0.5, 1:0.6, 1:0.7, 1:0.8, 1:0.9, etc.; preferably, the specific surface area of ​​the fumed silica is 250 to 400 m 2 / g, which can be listed, has a specific surface area of ​​250m 2 / g, 255m 2 / g, 260m 2 / g, 265m 2 / g, 270m 2 / g, 275m 2 / g, 280m 2 / g, 285m 2 / g, 290m 2 / g, 295m 2 / g、300m 2 / g, 305m 2 / g, 310m 2 / g, 315m 2 / g, 320m 2 / g, 325m 2 / g, 330m 2 / g, 335m 2 / g, 340m 2 / g, 345m2 / g, 350m 2 / g、355m 2 / g, 360m 2 / g, 365m 2 / g, 370m 2 / g, 375m 2 / g、380m 2 / g、385m 2 / g, 390m 2 / g, 400m 2 / g, etc. The specific surface area described in the present invention is the nitrogen adsorption specific surface area, which is a physical quantity used to measure the surface area size of the particles, and can be measured and confirmed according to the test method well known to those skilled in the art. Further preferably, the fumed silica is hydrophilic fumed silica, that is, a component that has been hydrophilically treated in a manner well known to those skilled in the art. In the present invention, the source of the fumed silica that meets the above requirements is not particularly limited, and commercially available related components are used, such as but not limited to the fumed silica HL series of Hubei Huifu Nanomaterials, such as HL200, HL-260, HL-300, HL-380, etc.

[0038] Furthermore, the particle size of the bentonite described in the present invention is not higher than 100 μm; the term particle size in the present invention is a physical quantity used to measure the average particle size of particles such as bentonite and / or fumed silica, and can be tested and confirmed in a manner familiar to those skilled in the art. In some preferred embodiments, the bentonite is composed of modified organic sodium-based bentonite and water-based bentonite. Among them, the water-based bentonite is a natural aluminosilicate component, and the main component is a substance obtained after hydrophilic modification of montmorillonite; the modified organic sodium-based bentonite is a component obtained by highly purifying and organically modifying sodium-calcium-based bentonite as a raw material; further preferably, the colloidal viscosity of a 3wt% aqueous solution of the water-based bentonite is not less than 3000cp; further, the bulk density of the water-based bentonite is 480-520kg / m 3 , which can be listed as 480kg / m 3 , 485kg / m 3 , 490kg / m 3 、495kg / m 3 , 500kg / m 3 , 505kg / m 3 、508kg / m 3 , 510kg / m 3 , 512kg / m 3 , 515kg / m 3 , 418kg / m 3 , 520kg / m 3The colloidal viscosity of the aqueous solution described in the present invention can be obtained by testing according to conventional means known to technicians. The bentonite described in the present invention can adopt commercially available related products, including but not limited to Kangbaixin CP series products.

[0039] In the dispersible oil suspension of emamectin benzoate and chlorfenapyr provided in the present invention, the functional adjuvant is a component used to improve the stability of the active ingredient and the processing performance of the dispersible oil suspension, so that the dispersible oil suspension can adhere well to the surface of the crop during the use of water, and improve the anti-scouring performance and other properties. It is a condensed ring compound, and the condensed ring compound is a carboxylate condensed ring compound. The condensed ring compound described in the present invention refers to a compound containing two or more benzene rings, naphthalene rings, substituted benzene rings, substituted naphthalene rings and other similar groups in the molecular structure. and structures; in some preferred embodiments, the functional additive includes sodium rosinate and / or disproportionated potassium rosinate. Further preferably, the functional additive is equal weight of sodium rosinate and disproportionated potassium rosinate. The sodium rosinate is a triphenyl ring structure anionic surfactant, CAS: 2305-85-3, and the disproportionated potassium rosinate is a product obtained by rearranging abietic resin acid molecules through hydrogen transfer through a disproportionation reaction of rosin in the presence of a catalyst, CAS: 38592-41-5. The content of the functional additive described in the present invention is 0.5-2wt%. For example, its content can be 0.5wt%, 0.6wt%, 0.7wt%, 0.8wt%, 0.9wt%, 1.0wt%, 1.1wt%, 1.2wt%, 1.3wt%, 1.4wt%, 1.5wt%, 1.6wt%, 1.7wt%, 1.8wt%, 1.9wt%, 2.0wt% and the like.

[0040] The applicant found that adding the active components of chlorantraniliprole and emamectin benzoate to an oil-based dispersion medium before emulsification and dispersion, and blending with an appropriate amount of sodium rosinate and potassium disproportionate rosinate can greatly improve the emulsification and dispersion effects. At the same time, after adding dispersants, stabilizers and other components to the formulation system, the above-mentioned functional additives can further enhance the mutual synergistic effect between these components, improve the physical and chemical properties of the preparation, so that it will not affect normal use under special environments such as high temperature and low temperature.

[0041] The oil-based dispersion medium described in the present invention is a vegetable oil, and the vegetable oil mainly includes but is not limited to soybean oil, corn oil, rapeseed oil, castor oil, coconut oil, palm oil, turpentine and vegetable oil esters and other compounds; preferably, the oil-based dispersion medium in the present invention adopts soybean oil. On the one hand, soybean oil has a low cost and can greatly reduce the preparation cost of the dispersible oil suspension in the present invention. On the other hand, soybean oil is more friendly to crops and environmentally friendly. However, the applicant found in the process of completing the present invention that the polarity of soybean oil is small and the hydrophilicity is too poor (HLB value is about 7), and the dispersibility and emulsification effect of the active component in the present invention are poor. Compared with conventional methyl oleate, the dispersion and emulsification effects of the two are significantly different, so it is necessary to optimize the components such as emulsifiers and dispersants in the dispersible oil suspension formulation system in a targeted manner, and the dispersion, emulsification and other effects of the dosage form are effectively improved by using the emulsifiers, dispersants and stabilizers and other components in the above-mentioned specific compounding ratios in the present invention.

[0042] The second aspect of the present invention provides a method for preparing the above-mentioned emamectin benzoate-chlorantraniliprole dispersible oil suspension, which comprises the following steps:

[0043] Step 1: taking chlorantraniliprole, emamectin benzoate and functional additives according to the ratio, adding them into a high-speed mixer and mixing to obtain an active component; wherein the speed, temperature and other parameters of the high-speed mixer are not particularly limited and can be adjusted according to actual needs, so that the active component is mixed with the functional additive and then mixed with the emulsifier and other components;

[0044] Step 2: adding the emulsifier to the oil-based dispersion medium, stirring and mixing, and then adding the active component and the dispersant under stirring conditions to obtain a mixture; in the process of mixing the emulsifier and the oil-based dispersion medium, appropriate heating and appropriate stirring speed can be adjusted according to actual needs, and after the oil-based dispersion medium and the emulsifier component are fully mixed, the above-treated active component is added; the above-mentioned active component can be added in batches;

[0045] Step 3: Add the mixed material into a grinder, shear and grind it into a material with a particle size of less than 5 microns, then add the remaining components, mix, and post-treat to obtain the product.

[0046] In the present invention, there is no special limitation on some specific process parameters such as temperature, stirring speed, rotation speed, feeding method, etc. in the above preparation method, and they can be adjusted and screened as needed according to methods familiar to those skilled in the art.

[0047] The present invention is described in detail below by way of examples. It is necessary to point out that the following examples are only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Some non-essential improvements and adjustments made by professionals and technicians in this field based on the content of the present invention still belong to the scope of protection of the present invention. In addition, if there is no other explanation, the raw materials used are all common commercial products.

[0048] Example 1

[0049] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0050]

[0051] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is monopalmitoyl glycerol (glyceryl monopalmitate) with an HLB value of 4.2, and the auxiliary emulsifier is a high HLB value emulsifier and a low HLB value emulsifier. The emulsifier is composed of castor oil / hydrogenated castor oil and ethylene oxide condensate (Nanhui EL-60) with an HLB value of about 15, and the low HLB emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite and the fumed silica is 1:0.8, the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1, and the bulk density of the modified organic sodium bentonite is 510kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0052] Example 2

[0053] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0054]

[0055] The dispersant is a polycarboxylate, and the polycarboxylate is a water-soluble polyacrylate (Shanghai Huntsman Tersperse2700); the emulsifier is composed of a high HLB value emulsifier and a low HLB value emulsifier, and the mass ratio is 1:2. The high HLB value emulsifier is a castor oil / hydrogenated castor oil and ethylene oxide condensate (Nanhui EL-60) with an HLB value of about 15, and the low HLB value emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite and the fumed silica is 1:0.8, and the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1. The bulk density of the modified organic sodium bentonite is 510kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0056] Example 3

[0057] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0058]

[0059] The dispersant is composed of polycarboxylate and sulfonate in a mass ratio of 1:1.8, the polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong); the emulsifier is monopalmitic acid glyceride (glycerol monopalmitate) with an HLB value of 4.2; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite and the fumed silica is 1:0.8, the bentonite is composed of modified organic sodium bentonite and water-based bentonite in a mass ratio of 1:1, and the bulk density of the modified organic sodium bentonite is 510kg / m 3The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0060] Example 4

[0061] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0062]

[0063] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is monopalmitoyl glycerol (glyceryl monopalmitate) with an HLB value of 4.2, and the auxiliary emulsifier is a high HLB value emulsifier and a low HLB value emulsifier. The emulsifier is composed of castor oil / hydrogenated castor oil and ethylene oxide condensate (Nanhui EL-60) with an HLB value of about 15, and the low HLB emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite and the fumed silica is 1:0.8, the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1, and the bulk density of the modified organic sodium bentonite is 510kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the oil-based dispersion medium is soybean oil.

[0064] Example 5

[0065] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0066]

[0067] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is monopalmitoyl glycerol (glycerol monopalmitate) with an HLB value of 4.2. The auxiliary emulsifier is composed of a high HLB value emulsifier and a low HLB value emulsifier, and the mass ratio is 1:2. The high HLB value emulsifier is a condensate of castor oil / hydrogenated castor oil and ethylene oxide (Nanhui EL-60) with an HLB value of about 15, and the low HLB value emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is fumed silica, and the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0068] Example 6

[0069] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0070]

[0071]

[0072] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is glyceryl monopalmitate (glyceryl monopalmitate) with an HLB value of 4.2. The auxiliary emulsifier is composed of a high HLB value emulsifier and a low HLB value emulsifier, and the mass ratio is 1:2. The high HLB value emulsifier is a condensate of castor oil / hydrogenated castor oil and ethylene oxide (Nanhui EL-60) with an HLB value of about 15, and the low HLB value emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is bentonite, and the bentonite is a modified organic sodium bentonite, and the bulk density of the modified organic sodium bentonite is 510kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300 m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0073] Example 7

[0074] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0075]

[0076] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is monopalmitoyl glycerol (glyceryl monopalmitate) with an HLB value of 4.2, and the auxiliary emulsifier is a high HLB value emulsifier and a low HLB value emulsifier. The emulsifier is composed of castor oil / hydrogenated castor oil and ethylene oxide condensate (Nanhui EL-60) with an HLB value of about 15, and the low HLB emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite and the fumed silica is 1:0.8, the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1, and the bulk density of the modified organic sodium bentonite is 510kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is an equal weight of sodium rosin acid; the oil-based dispersion medium is soybean oil.

[0077] Example 8

[0078] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0079]

[0080] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is monopalmitoyl glycerol (glycerol monopalmitate) with an HLB value of 4.2. The auxiliary emulsifier is composed of a high HLB value emulsifier and a low HLB value emulsifier, and the mass ratio is 1:2. The high HLB value emulsifier is a condensate of castor oil / hydrogenated castor oil and ethylene oxide (Nanhui EL-60) with an HLB value of about 15, and the low HLB value emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is fumed silica, and the fumed silica is hydrophobic fumed silica with an average specific surface area of ​​170m 2 / g (Hubei Huifu Nano HB-152); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0081] Example 9

[0082] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0083]

[0084] The dispersant is composed of polycarboxylate and sulfonate, and the mass ratio is 1:1.8. The polycarboxylate is a water-soluble polyacrylic acid salt (Shanghai Huntsman Tersperse2700), and the sulfonate is an oil-soluble anionic sulfonate polymer (GY-EM05 of Beijing Guangyuan Yinong). The emulsifier is composed of a primary emulsifier and an auxiliary emulsifier, and the mass ratio of the primary emulsifier and the auxiliary emulsifier is 3:2. The primary emulsifier is monopalmitoyl glycerol (glyceryl monopalmitate) with an HLB value of 4.2, and the auxiliary emulsifier is a high HLB value emulsifier and a low HLB value emulsifier. The emulsifier is composed of castor oil / hydrogenated castor oil and ethylene oxide condensate (Nanhui EL-60) with an HLB value of about 15, and the low HLB emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite and the fumed silica is 1:0.8, the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1, and the bulk density of the modified organic sodium bentonite is 510kg / m 3The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosin acid and potassium disproportionate rosin acid in equal weights; the oil-based dispersion medium is methyl oleate.

[0085] Example 10

[0086] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0087]

[0088] The dispersant is a modified lignin dispersant (GY-DM18 of Beijing Guangyuan Yino); the emulsifier is composed of a main emulsifier and an auxiliary emulsifier, the mass ratio of the main emulsifier and the auxiliary emulsifier is 3:2, the main emulsifier is monopalmitic acid glyceride (glycerol monopalmitate) with an HLB value of 4.2, and the auxiliary emulsifier is composed of a high HLB value emulsifier and a low HLB value emulsifier, the mass ratio is 1:2, and the high HLB value emulsifier is castor oil / hydrogen The condensate of castor oil and ethylene oxide (Nanhui EL-60) is prepared; the low HLB value emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite to the fumed silica is 1:0.8; the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1; the bulk density of the modified organic sodium bentonite is 510 kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0089] Embodiment 11

[0090] This embodiment provides a 19.4 wt% emamectin benzoate and chlorfenapyr dispersible oil suspension, which includes the following components in parts by weight:

[0091]

[0092] The dispersant is a nonionic EO / PO block polyether wetting dispersant ( 500L1), cloud point is about 52°C; the emulsifier is composed of a main emulsifier and an auxiliary emulsifier, the mass ratio of the main emulsifier and the auxiliary emulsifier is 3:2, the main emulsifier is monopalmitic acid glyceride (glycerol monopalmitate) with an HLB value of 4.2, the auxiliary emulsifier is composed of a high HLB value emulsifier and a low HLB value emulsifier, the mass ratio is 1:2, the high HLB value emulsifier is castor oil / hydrogenated castor oil with an HLB value of about 15 and ethylene oxide The low HLB value emulsifier is an alkylphenol polyoxyethylene ether (Nanhui TX-4) with an HLB value of about 8.5; the stabilizer is a mixture of bentonite and fumed silica, wherein the mass ratio of the bentonite to the fumed silica is 1:0.8, the bentonite is composed of modified organic sodium bentonite and water-based bentonite, and the mass ratio is 1:1. The bulk density of the modified organic sodium bentonite is 510kg / m 3 The average particle size is 76 μm (Kangbaixin CP-27A), the average particle size of the aqueous bentonite is 74 μm, and the colloid viscosity of the 3wt% aqueous solution is ≥3000cp (Kangbaixin CP-EWS); the fumed silica is hydrophilic fumed silica with an average specific surface area of ​​300m 2 / g (Hubei Huifu Nano HL-300); the functional additive is a mixture of sodium rosinate and potassium disproportionate rosinate in equal weights; the oil-based dispersion medium is soybean oil.

[0093] Field trials

[0094] The applicant conducted a field efficacy test on the 19.4wt% chlorfenapyr dispersible oil suspension in Example 1 for controlling corn borers, wherein the test crop was corn, the variety was Ganyu 170; the control target was corn borer (Ostriniafurnacalis, O.nubilalis); the application method and water consumption were: the whole plant uniform spraying method was adopted, and 750L of the solution was sprayed per hectare.

[0095] Table 1 Basic information of the test substances

[0096]

[0097] Test results:

[0098] Table 219.4% chlorfenapyr dispersible oil suspension (Example 1) Field efficacy test results for controlling corn borer

[0099]

[0100]

[0101] For details of the field efficacy test report, please refer to the report numbered JS20232C017-BG issued by Gansu Jinsu Agricultural Technology Co., Ltd.

[0102] Physical and chemical performance evaluation

[0103] (1) Low temperature stability:

[0104] The applicant placed the samples in the above embodiments in a constant temperature and humidity chamber at 4°C and 55% humidity for 24 hours for low temperature treatment, and then took out the samples to observe the dispersion state and emulsification state of the dispersible oil suspension samples, and divided them into 1 to 5 levels according to their dispersion state and emulsification state; the samples after low temperature treatment can be quickly and automatically dispersed uniformly and recorded as dispersion state level 1; the samples after low temperature treatment can be automatically and uniformly dispersed and recorded as dispersion state level 2; the samples after low temperature treatment are white cloud-like or filamentous dispersion and recorded as dispersion state level 3; the samples after low temperature treatment sink in the form of white particles and are recorded as dispersion state level 4; the samples after low temperature treatment sink in the form of oil droplets and are recorded as dispersion state level 5.

[0105] In the above embodiment, the sample treated at low temperature is taken out and slightly stirred to form a blue or light white transparent emulsion, which is recorded as the first emulsified state; the sample treated at low temperature is taken out and slightly stirred to form a blue translucent emulsion, which is recorded as the second emulsified state; the sample treated at low temperature is taken out and stirred to form a blue opaque emulsion, which is recorded as the third emulsified state; the sample treated at low temperature is taken out and stirred to form a white opaque emulsion, which is recorded as the fourth emulsified state; the sample treated at low temperature can be emulsified when stirred after being taken out, and the emulsified state is recorded as the fifth emulsified state. The test results are shown in Table 3 below.

[0106] Table 3 Low temperature stability

[0107]

[0108]

[0109] (2) Dilution stability

[0110] The applicant evaluated the dilution effect of the dispersible oil suspension samples in the above embodiments by diluting each sample 500 times with water at about 4°C, stirring thoroughly and placing it in a constant temperature box at 10°C for two hours, and then observing the state of the diluted agent. The agent was scored from level one to level four from the perspectives of dispersion uniformity, stratification, precipitation, and transparency change of the suspension. The agent after water treatment can form tiny oil droplets in the aqueous solution, and these particles are fully and evenly dispersed in the water without stratification, precipitation, etc., and the rating is level one; the agent after treatment has some oil droplet particles agglomeration or stratification, but can basically be redispersed after stirring again, and the rating is level two; the agent after treatment has some oil droplet particles agglomeration and stratification, and still cannot be redispersed after stirring again, and the rating is level three; the agent after treatment has obvious stratification and precipitation, and the precipitation does not completely disappear after stirring, and the rating is level four. The experimental results are shown in Table 4 below.

[0111] Table 4 Dilution stability

[0112]

[0113]

[0114] (3) Stability against rainwater erosion

[0115] The applicant conducted a rain erosion resistance stability test on the samples in the above embodiments. Specifically: each sample was diluted 500 times with the same water and then evenly sprayed on the selected soybean leaves of basically the same size and shape using a manual sprayer. The same amount of agent was used. After being placed at room temperature for one hour, the leaves were simulated for rainfall. A laboratory spray pot was used to spray the same amount of water on the above leaves at the same pressure, and the residual condition of the drug film formed on the surface of the leaves was observed. The rain erosion resistance effect was characterized according to the amount of residual condition of the drug film. Among them, if a complete drug film is formed, and the integrity of the drug film can be basically guaranteed after simulating rainfall, and there is no obvious drug erosion visible to the naked eye, it is rated as level one; if there is obvious drug erosion, but more than half of the drug remains, it is rated as level 2; if the drug film is obviously washed away in large quantities, and the residual amount is obviously below average, it is rated as level three. The results are shown in Table 5.

[0116] Table 5 Rainwater erosion resistance stability

[0117]

[0118]

[0119] Finally, it should be noted that the above are only some preferred embodiments of the present invention and are not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, it is still possible for those skilled in the art to modify the technical solutions described in the aforementioned embodiments or to make equivalent substitutions for some of the technical features therein. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A dispersible oil suspension of emamectin benzoate and chlorfenapyr, characterized in that: It includes the following components in parts by weight: Among them, the functional auxiliary agent is a condensed ring compound, and the condensed ring compound is a carboxylate condensed ring compound; the oil-based dispersion medium is vegetable oil; the emulsifier is a composite emulsifier containing at least two or more emulsifying components with different HLB values, and the composite emulsifier includes an emulsifier with an HLB value not higher than 10; the dispersant is an ionic surfactant.

2. The emamectin benzoate-chlorantraniliprole dispersible oil suspension according to claim 1, characterized in that: The composite emulsifier includes a primary emulsifier, and the HLB value of the primary emulsifier is not higher than 6; the content of the primary emulsifier accounts for at least 50wt% or more of the total content of the composite emulsifier; preferably, the composite emulsifier also includes an auxiliary emulsifier, and the HLB value of the auxiliary emulsifier is higher than that of the primary emulsifier.

3. The dispersible oil suspension concentrate of emamectin benzoate and chlorfenapyr according to claim 2, characterized in that: The composite emulsifier further comprises a co-emulsifier, and the co-emulsifier comprises at least two emulsifier components with different HLB values.

4. The emamectin benzoate-chlorantraniliprole dispersible oil suspension according to claim 3, characterized in that: The auxiliary emulsifier includes a high HLB emulsifier and a low HLB emulsifier, the HLB value of the high HLB emulsifier is 13-16, and the HLB value of the low HLB emulsifier is 7-10; preferably, the mass ratio of the high HLB emulsifier to the low HLB emulsifier is 1:(1.5-2.5).

5. The dispersible oil suspension concentrate of emamectin benzoate and chlorfenapyr according to claim 1, characterized in that: The dispersant comprises polycarboxylate and sulfonate; the mass ratio of the polycarboxylate to the sulfonate is 1:(1-2).

6. The emamectin benzoate-chlorantraniliprole dispersible oil suspension according to claim 1, characterized in that: The stabilizer is a mixture of bentonite and fumed silica; the content of the bentonite is higher than the content of the fumed silica; preferably, the specific surface area of ​​the fumed silica is 250 to 400 m 2 / g.

7. The dispersible oil suspension concentrate of emamectin benzoate and chlorfenapyr according to claim 6, characterized in that: The particle size of the bentonite is not higher than 100 μm; the bentonite consists of modified organic sodium-based bentonite and water-based bentonite.

8. The dispersible oil suspension concentrate of emamectin benzoate and chlorfenapyr according to claim 7, characterized in that: The colloidal viscosity of a 3 wt % aqueous solution of the aqueous bentonite is not less than 3000 cp.

9. The dispersible oil suspension concentrate of emamectin benzoate and chlorfenapyr according to claim 1, characterized in that: The functional auxiliary agent includes sodium rosinate and / or potassium disproportionated rosinate.

10. The method for preparing the dispersible oil suspension concentrate of emamectin benzoate and chlorfenapyr according to any one of claims 1 to 9, characterized in that: It includes the following steps: Step 1: taking chlorantraniliprole, emamectin benzoate and functional adjuvant according to the ratio, adding them into a high-speed mixer and mixing to obtain an active component; Step 2: adding the emulsifier to the oil-based dispersion medium, stirring and mixing, and then adding the active component and the dispersant under stirring conditions to obtain a mixture; Step 3: Add the mixed material into a grinder, shear and grind it into a material with a particle size of less than 5 microns, then add the remaining components, mix, and post-treat to obtain the product.